Balyasny Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Sell |
126,145
-1,690,864
| -93% | -$15.8M | ﹤0.01% | 1342 |
|
|
2025
Q1 | $22.3M | Buy |
1,817,009
+1,747,423
| +2,511% | +$21.5M | 0.04% | 413 |
|
|
2024
Q4 | $920K | Sell |
69,586
-297,591
| -81% | -$3.93M | ﹤0.01% | 1306 |
|
|
2024
Q3 | $7.07M | Buy |
+367,177
| New | +$7.07M | 0.01% | 768 |
|
|
2024
Q1 | – | Sell |
-165,018
| Closed | -$3.57M | – | 2401 |
|
|
2023
Q4 | $3.57M | Buy |
165,018
+16,494
| +11% | +$356K | 0.01% | 876 |
|
|
2023
Q3 | $2.16M | Buy |
148,524
+48,850
| +49% | +$709K | ﹤0.01% | 983 |
|
|
2023
Q2 | $2.09M | Buy |
99,674
+80,572
| +422% | +$1.69M | ﹤0.01% | 1011 |
|
|
2023
Q1 | $403K | Buy |
+19,102
| New | +$403K | ﹤0.01% | 1586 |
|
|
2018
Q3 | – | Sell |
-10,413
| Closed | -$73K | – | 1736 |
|
|
2018
Q2 | $73K | Sell |
10,413
-4,400
| -30% | -$30.8K | ﹤0.01% | 1545 |
|
|
2018
Q1 | $211K | Sell |
14,813
-33,993
| -70% | -$484K | ﹤0.01% | 1554 |
|
|
2017
Q4 | $428K | Buy |
+48,806
| New | +$428K | ﹤0.01% | 1357 |
|